Speaker illustration

Mr Nikolaos Mylonas

Athens (Greece)

Comparative study on the cardioprotective effects against ischemia/reperfusion injury of the selective SGLT2 inhibitors, empagliflozin, dapagliflozin and ertugliflozin in non-diabetic mice

Event: ESC Congress 2021 - The Digital Experience

Topic: Ischaemia, Infarction, Cardioprotection

Session: Basic science e-posters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb